医学
不良事件通用术语标准
肾功能
泌尿科
内科学
不利影响
肿瘤科
作者
Moritz B. Bastian,Maike Sieben,Caroline Burgard,Arne Blickle,Tilman Speicher,Mark Bartholomä,Stephan Maus,Sven Petto,Andrea Schaefer-Schuler,Samer Ezziddin,Florian Rosar
标识
DOI:10.1097/rlu.0000000000005583
摘要
PSMA-RLT is an effective and safe treatment in mCRPC patients with preexisting impaired renal function (CTCAE ≥2). In daily clinical practice, patients should not be categorically excluded from enrolment to PSMA-RLT due to renal impairment.
科研通智能强力驱动
Strongly Powered by AbleSci AI